Dodda Brahmam

ORCID: 0000-0003-1127-2629
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Long-Term Effects of COVID-19
  • Thermal Regulation in Medicine
  • COVID-19 Clinical Research Studies
  • Respiratory Support and Mechanisms
  • Sepsis Diagnosis and Treatment
  • Intensive Care Unit Cognitive Disorders
  • Cardiac electrophysiology and arrhythmias
  • Cardiovascular Function and Risk Factors
  • Airway Management and Intubation Techniques
  • Congenital Diaphragmatic Hernia Studies
  • Tracheal and airway disorders
  • Cardiac Valve Diseases and Treatments

Sree Chitra Thirunal Institute for Medical Sciences and Technology
2024

All India Institute of Medical Sciences Bhopal
2020-2022

All India Institute of Medical Sciences
2020

Tracheostomy is integral in long-term intensive care of coronavirus disease-2019 (COVID-19) patients. There a paucity studies on weaning outcomes and mortality after tracheostomy COVID-19 Indian scenario.We conducted retrospective, single-center, observational study severe patients who underwent elective (n = 65) during critical tertiary institute Central India from May 1, 2020, to April 30, 2021. Data were collected Medical records, ICU charts, follow-up visits by patient. A primary...

10.5005/jp-journals-10071-24080 article EN Indian Journal of Critical Care Medicine 2022-01-01

Major adverse cardiac events (MACE) are frequent in coronavirus disease-2019 (COVID-19). Remdesivir is used worldwide for treatment COVID-19. In this retrospective observational study, our primary objective was to assess the impact of remdesivir administration on incidence MACE and associated 28 day survival critically ill patients admitted moderate severe COVID-19 pneumonia.We analyzed data 437 intensive care unit (ICU) divided them into two groups: R group (received at ICU admission) NR...

10.5005/jp-journals-10071-24189 article EN Indian Journal of Critical Care Medicine 2022-08-31

Abstract Introduction Steroids have shown its usefulness in critically ill COVID19 patients. However time of starting steroid and dose tailored to severity remains a matter inquiry due still emerging evidences wide-ranging concerns benefits harms. We did retrospective record analysis an apex teaching hospital ICU setting explore optimal doses duration therapy which can decrease mortality. Methodology 114 adults with COVID19-ARDS admitted between 20 th March-15 August2020 were included chart...

10.1101/2020.08.19.20171868 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2020-08-22

Steroids have shown its usefulness in critically ill COVID-19 patients. However, the time of starting steroid and dose tailored to severity remain a matter inquiry due still emerging evidences wide-ranging concerns benefits harms. We did retrospective record analysis an apex teaching hospital ICU setting explore optimal doses duration therapy which can decrease mortality.114 adults with COVID-19-ARDS admitted between 20th March-15th August 2020 were included chart review. preliminary...

10.2174/2772434417666220817121439 article EN Recent Advances in Anti-Infective Drug Discovery 2022-08-18

Background:The outcomes in critical illness depend on disease severity, practice protocols, workload, and access to care.This study investigates the factors affecting mechanically ventilated coronavirus disease-2019 acute respiratory distress syndrome (COVID-19 ARDS) patients admitted a tertiary teaching hospital intensive care unit (ICU) Central India with reference different time periods pandemic.This is one of largest series COVID-19 ARDS patients, globally.Methods: This retrospective...

10.5005/jp-journals-10071-24279 article EN Indian Journal of Critical Care Medicine 2022-08-31

Introduction: Steroids have shown its usefulness in critically ill COVID19 patients. However time of starting steroid and dose tailored to severity remains a matter inquiry due still emerging evidences wide-ranging concerns benefits harms. We did retrospective record analysis an apex teaching hospital ICU setting explore optimal doses duration therapy which minimizes the hazard death.Methodology: 114 adults with COVID19-ARDS admitted between 20th March-15th August 2020 were included chart...

10.2139/ssrn.3688878 article EN SSRN Electronic Journal 2020-01-01
Coming Soon ...